* 中港医药板块周二双双劲升，恒生创新药指数.HSIDI盘中一度大涨7.1%，中证医药100指数.CSI000978早盘收升3.5%。
* 恒瑞医药600276.SS、智飞生物300122.SZ、复星医药2196.HK600196.SS、石药集团1093.HK、康方生物9926.HK涨幅介于5.6-15%。
* 中信证券研报称，医疗健康产业较多子行业在2025 Q1 有望呈现出需求或业绩修复的趋势，相关上市公司从整体来看2025 Q1 业绩表现预期较为稳健。得益于集采等政策优化向好、商保推动和AI赋能，板块有望迎来估值重估且催化预计将延续全年，判断医疗健康产业相关上市公司全年整体的收入、利润、现金流将稳健修复向好。
中信建议积极布局医疗健康产业投资机会，板块估值迎来价值重估，底部布局正当时。 （完）
更多股市简讯请点选CN-CMN-HOT
(发稿 宿泱韫；审校 田镧沁)
((jenny.su@thomsonreuters.com; 86-10-56692102;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.